ACC Expert Statement Addresses Frailty and Cognitive Impairment in Cardiovascular Care

Cardiovascular Disease Accelerates Cognitive Decline in Older Adults

Older adults dealing with cardiovascular disease face a significantly higher risk of cognitive impairment, according to a clinical statement issued on June 1, 2026, by the American College of Cardiology.

Conditions like hypertension, heart failure, atrial fibrillation, and coronary artery disease drive this elevated risk. This vulnerability is frequently complicated by overlapping health issues such as frailty, sarcopenia, and social isolation.

Self-Management Hurdles and Communication Barriers in Clinical Settings

Managing cardiovascular care in this vulnerable population presents distinct hurdles that standard treatment models rarely address.

Recognizing subtle health shifts, such as early weight gain or blood pressure fluctuations, becomes difficult when cognitive function drops.

Furthermore, social discomfort or embarrassment can prevent patients from asking necessary questions during medical visits, delaying timely interventions.

The Escalating Danger of Polypharmacy and Complex Drug Regimens

Polypharmacy adds another layer of clinical complexity.

Data cited in the American College of Cardiology guidance show that among 558 Medicare-insured adults aged 65 and older who were hospitalized for heart failure, 84 percent took five or more medications at admission. That figure jumped to 95 percent by hospital discharge.

42 percent of these patients took 10 or more medications at admission, increasing to 55 percent at discharge. Cardiac regimens requiring multiple daily doses, careful titration, and strict side-effect monitoring test the limits of both patients and their caregivers.

Invasive Interventions and the Strain on Surrogate Decision-Makers

Treatment-related adverse events occur more frequently in individuals with dementia or moderate-to-severe cognitive impairment.

Percutaneous coronary interventions carry heightened risks for these patients, including higher rates of in-hospital delirium, mortality, kidney injury, falls, and 30-day readmissions, according to the American College of Cardiology document.

When decisional capacity falters, surrogate decision-makers must step in, making shared decision-making significantly more complicated.

The Blind Spot of Clinical Trials and Lacking Evidence-Based Guidance

A major driver of inconsistent care patterns is the historical exclusion of cognitively impaired adults from major cardiovascular clinical trials.

Because trial data primarily reflect cognitively intact populations, clinicians often must extrapolate treatment strategies from observational data.

This lack of tailored evidence frequently leads to heterogeneous management styles dictated by institutional practice rather than robust data, resulting in either overly conservative approaches or more intensive treatment in vulnerable patients.

Structured Frameworks and Practical Solutions to Reduce Care Fragmentation

To combat these barriers, the American College of Cardiology recommends structured frameworks that emphasize goal-concordant care, advance care planning, and early palliative care involvement.

Practical strategies for clinicians include providing patients with simple, literacy-matched printed instructions detailing symptom monitoring and adverse event tracking.

Establishing a single designated point of contact, utilizing structured telephone support, and engaging caregivers directly can help reduce care fragmentation.